Philly DA Accuses Drugmakers Of Deceptive Opioid Marketing

Law360 (February 2, 2018, 7:49 PM EST) -- Philadelphia’s district attorney took aim at the pharmaceutical industry on Friday as his office launched a lawsuit accusing a slew of drugmakers, including Johnson & Johnson and Teva Pharmaceuticals USA Inc., of fueling the opioid crisis through deceptive marketing of painkillers.

The suit is the latest in a string of cases — the city of Philadelphia filed its own independent action in mid-January — being pursued around the country against major drugmakers for allegedly irresponsible promotion of addictive opioid medication for use treating long-term pain.

The complaint said that the drugmakers “engaged in massive, systemic, false and deceptive marketing aggressively promoting...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS